EMEA-002012-PIP01-16-M03
Key facts
| Invented name |
Namuscla
|
| Active substance |
Mexiletine hydrochloride
|
| Therapeutic area |
Other
|
| Decision number |
P/0365/2021
|
| PIP number |
EMEA-002012-PIP01-16-M03
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of myotonic disorders
|
| Route(s) of administration |
|
| Contact for public enquiries |
Lupin Europe GmbH
Tel. +41 526337025 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|